For Research Use Only. Not for use in diagnostic procedures.
BENEFITS
Menarini Silicon Biosystems offers the new Circulating Multiple Myeloma Cell (CMMC) test to study the disease biology of multiple myeloma and precursor disease states. Our antibody-based CELLSEARCH® technology captures and identifies CD138+ plasma cells which can be used to monitor disease progression in clinical research studies. Using our new CellRescue™ Tube, peripheral blood samples can be sent from anywhere in the world at room temperature to our Global Laboratory Service sites in the United States and Italy for CMMC identification and enumeration.
Liquid biopsy test with high sensitivity and specificity
Advancing the Field of Liquid Biopsy with
the Circulating Multiple Myeloma Cell Test
Our unique blood collection tube provides a 96-hour window from collection to testing
Results available approximately 2 days post sample arrival to lab
Non-invasive access to CMMCs using a simple blood draw versus painful bone marrow biopsies
Option to freeze cells for downstream applications
15+ years of experienced lab personnel performing global clinical trial testing and providing results
Hover Over to Explore Additional Resources
WEBINAR:
ARTICLE:
BLOG:
Pharma & Clinical Service Experience
Stable Sample
Storage & Transport
Global Lab Services Brochure
Lab Accreditations
US (Huntingdon Valley, PA) Lab:
- CLIA Certified and ISO 15189 accredited for CELLSEARCH® CTC testing in the US
Italy (Bologna) Lab:
- Mirror lab shares the same Quality Management System
- ISO 15189 accreditation expected
first half of 2021
CMMC assay will be submitted
for CLIA certification
Click here to view our Global Lab Services brochure
MSB's proprietary CellRescue™ and CellSave® tubes provide sample stability for up to 96 hours at room temperature, allowing shipment of samples from remote locations to enable global clinical trials.
- 13 years global clinical trial expertise
- Proven track record of success in quality, regulatory, & pharmaceutical company audits
- # Samples handled: 25,000+
- # Clinical trials: ~60
- # Pharma partnerships: 25+
Developing a Novel Assay for Circulating Multiple Myeloma Cells Using the CELLSEARCH® Platform
Dr. Irene Ghobrial M.D., Dana-Farber Cancer Institute
Sara Lazaro
Head of Clinical Lab Operations & Services, MSB
Steven Gross
Head of Assay Development, MSB
Click here to watch
the recorded webinar
"Assay Development Case Study: How Custom Assay Development Helped Spur Precision Medicine Research in Multiple Myeloma" by Steven Gross
Published in the October 2020 issue of Drug Development & Delivery
Click here to read the article
"Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services"
by Sara Lazaro
Posted on Xtalks.com, December 1, 2020
Click here to read the blog
In addition to our Global Lab Services, we offer the below unique rare cell technologies and products that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization.
Genetic Analysis
Sample Preparation
This CELLSEARCH® to DEPArray™ workflow described is for Research Use Only.
The CELLSEARCH® CMMC assay is for Research Use Only. Not for use in Diagnostic Procedures.
CELLSEARCH® for Clinicians (IVD)
CELLSEARCH® for Researchers (RUO)
Click here to request additional information
2020 Menarini Silicon Biosystems Inc. All rights reserved.
Explore our technologies and products by clicking on the icons
Explore our technologies and products by clicking on the icons
